Skip to content
← Back to this collection

PUBLICATIONS · 15470213

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2004 Oct 7
First author
Tannock IF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2004 Oct 7;351(15):1488-90. doi: 10.1056/NEJMp048178.
    note
    Source null
    related pmid
    15470210
    relationship
    Comment in
  2. citation
    Curr Oncol Rep. 2005 May;7(3):205-6. doi: 10.1007/s11912-005-0074-1.
    note
    Source null
    related pmid
    15847711
    relationship
    Comment in
  3. citation
    Cancer Treat Rev. 2005 Aug;31(5):403-7. doi: 10.1016/j.ctrv.2005.05.003.
    note
    Source null
    related pmid
    16169665
    relationship
    Comment in

Authors and identifiers

  1. name
    Tannock IF
    type
    Author
  2. name
    de Wit R
    type
    Author
  3. name
    Berry WR
    type
    Author
  4. name
    Horti J
    type
    Author
  5. name
    Pluzanska A
    type
    Author
  6. name
    Chi KN
    type
    Author
  7. name
    Oudard S
    type
    Author
  8. name
    Théodore C
    type
    Author
  9. name
    James ND
    type
    Author
  10. name
    Turesson I
    type
    Author
  11. name
    Rosenthal MA
    type
    Author
  12. name
    Eisenberger MA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tannock IF
    type
    Author
  2. name
    de Wit R
    type
    Author
  3. name
    Berry WR
    type
    Author
  4. name
    Horti J
    type
    Author
  5. name
    Pluzanska A
    type
    Author
  6. name
    Chi KN
    type
    Author
  7. name
    Oudard S
    type
    Author
  8. name
    Théodore C
    type
    Author
  9. name
    James ND
    type
    Author
  10. name
    Turesson I
    type
    Author
  11. name
    Rosenthal MA
    type
    Author
  12. name
    Eisenberger MA
    type
    Author
bibliography ids
  1. nci-bib-27ea9e8cbff9b08eacdcd535
book metadata
content sha256
dca72b241c8adc834613b1eb2c063d0a9d73ee9a3508cd1584b608aa80bada9d
document type
citation
dois
  1. 10.1056/NEJMoa040720
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15470213
immutable id
pubmed:15470213@dca72b241c8adc834613b1eb2c063d0a9d73ee9a3508cd1584b608aa80bada9d
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
15
name
The New England journal of medicine
nlm unique id
0255562
pages
1502-12
volume
351
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2004 Oct 7;351(15):1488-90. doi: 10.1056/NEJMp048178.
    note
    Source null
    related pmid
    15470210
    relationship
    Comment in
  2. citation
    Curr Oncol Rep. 2005 May;7(3):205-6. doi: 10.1007/s11912-005-0074-1.
    note
    Source null
    related pmid
    15847711
    relationship
    Comment in
  3. citation
    Cancer Treat Rev. 2005 Aug;31(5):403-7. doi: 10.1016/j.ctrv.2005.05.003.
    note
    Source null
    related pmid
    16169665
    relationship
    Comment in
outcomes validated
false
pmid
15470213
provenance
batch id
97b9e848a139d5f8d462
provider
NCBI PubMed ESummary
record sha256
c0705c0c19fa5b544ef53c98054ae8f52b15b01e3d4f86dbd897819476d71ccf
response sha256
a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
retrieved at
2026-09-09T23:45:57.930512+00:00
publication date
display
2004 Oct 7
precision
day
year
2004
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Multicenter Study
  6. Randomized Controlled Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15470213/
title
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

Preserved source evidence · Not medical advice